1. Home
  2. EMAT vs SHC Comparison

EMAT vs SHC Comparison

Compare EMAT & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Metals & Technologies Corp. Common Stock

EMAT

Evolution Metals & Technologies Corp. Common Stock

N/A

Current Price

$3.31

Market Cap

4.4B

Sector

N/A

ML Signal

N/A

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$18.02

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMAT
SHC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EMAT
SHC
Price
$3.31
$18.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$30.00
$20.33
AVG Volume (30 Days)
82.4K
2.8M
Earning Date
05-18-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.75
EPS
N/A
0.09
Revenue
N/A
$1,163,617,000.00
Revenue This Year
N/A
$7.51
Revenue Next Year
$2,122.43
$6.00
P/E Ratio
N/A
$198.44
Revenue Growth
N/A
5.74
52 Week Low
$3.65
$11.00
52 Week High
$17.50
$19.85

Technical Indicators

Market Signals
Indicator
EMAT
SHC
Relative Strength Index (RSI) 19.25 58.73
Support Level N/A $16.57
Resistance Level $7.62 $18.55
Average True Range (ATR) 0.46 0.49
MACD -0.12 -0.04
Stochastic Oscillator 6.13 70.12

Price Performance

Historical Comparison
EMAT
SHC

About EMAT Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Share on Social Networks: